Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1984 Jul;52(1):63–71. doi: 10.1136/hrt.52.1.63

Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure.

S K Mujais, F M Fouad, S C Textor, R C Tarazi, E L Bravo, N Hart, R W Gifford Jr
PMCID: PMC481586  PMID: 6378228

Abstract

Treatment with captopril in resistant normotensive congestive heart failure is associated with a pronounced reduction in blood pressure, particularly after the first dose. The effects of this reduction on renal function were assessed in 10 patients at the beginning of and during chronic treatment (at one week and three months). Renal plasma flow and glomerular filtration rates were measured by isotope clearance during water diuresis. The first dose of captopril (25 mg) led to a pronounced fall in renal plasma flow and glomerular filtration rates together with a decrease in mean arterial pressure; this fall correlated with baseline plasma renin activity. These changes were paralleled by decreases in water and sodium excretion. In contrast, by the end of the first week of treatment a similar fall in mean arterial pressure occurred together with a pronounced increase in renal plasma flow; the glomerular filtration rate was maintained and there was no decrease in water and sodium excretion. This new response pattern recurred after three months of treatment. The difference in response at different stages of treatment may reflect the balance between the different mechanisms influencing kidney dynamics in heart failure and their alteration by converting enzyme inhibition. The sustained increase in renal plasma flow during chronic treatment with captopril may account for the continued control of heart failure in these patients.

Full text

PDF
69

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROD J., FEJFAR Z., FEJFAROVA M. H. The role of neuro-humoral factors in the genesis of renal haemodynamic changes in heart failure. Acta Med Scand. 1954;148(4):273–290. doi: 10.1111/j.0954-6820.1954.tb01720.x. [DOI] [PubMed] [Google Scholar]
  2. Blythe W. B. Captopril and renal autoregulation. N Engl J Med. 1983 Feb 17;308(7):390–391. doi: 10.1056/NEJM198302173080709. [DOI] [PubMed] [Google Scholar]
  3. Bravo E. L., Tarazi R. C. Converting enzyme inhibition with an orally active compound in hypertensive man. Hypertension. 1979 Jan-Feb;1(1):39–46. doi: 10.1161/01.hyp.1.1.39. [DOI] [PubMed] [Google Scholar]
  4. Bravo E. L., Tarazi R. C., Dustan H. P. On the mechanism of suppressed plasma-renin activity during beta-adrenergic blockade with propranolol. J Lab Clin Med. 1974 Jan;83(1):119–128. [PubMed] [Google Scholar]
  5. Bravo E. L., Tarazi R. C., Gifford R. W., Stewart B. H. Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. N Engl J Med. 1979 Sep 27;301(13):682–686. doi: 10.1056/NEJM197909273011302. [DOI] [PubMed] [Google Scholar]
  6. Brown J. J., Davies D. L., Lever A. F., Parker R. A., Robertson J. I. The assay of renin in single glomeruli and the appearance of the juxtaglomerular apparatus in the rabbit following renal artery constriction. Clin Sci. 1966 Apr;30(2):223–235. [PubMed] [Google Scholar]
  7. Cannon P. J. The kidney in heart failure. N Engl J Med. 1977 Jan 6;296(1):26–32. doi: 10.1056/NEJM197701062960108. [DOI] [PubMed] [Google Scholar]
  8. Chrysant S. G., Dunn M., Marples D., DeMasters K. Severe reversible azotemia from captopril therapy. Report of three cases and review of the literature. Arch Intern Med. 1983 Mar;143(3):437–441. [PubMed] [Google Scholar]
  9. Click R. L., Joyner W. L., Gilmore J. P. Reactivity of gomerular afferent and efferent arterioles in renal hypertension. Kidney Int. 1979 Feb;15(2):109–115. doi: 10.1038/ki.1979.16. [DOI] [PubMed] [Google Scholar]
  10. Cogan J. J., Humphreys M. H., Carlson C. J., Rapaport E. Renal effects of nitroprusside and hydralazine in patients with congestive heart failure. Circulation. 1980 Feb;61(2):316–323. doi: 10.1161/01.cir.61.2.316. [DOI] [PubMed] [Google Scholar]
  11. Creager M. A., Halperin J. L., Bernard D. B., Faxon D. P., Melidossian C. D., Gavras H., Ryan T. J. Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure. Circulation. 1981 Sep;64(3):483–489. doi: 10.1161/01.cir.64.3.483. [DOI] [PubMed] [Google Scholar]
  12. Curtis J. J., Luke R. G., Whelchel J. D., Diethelm A. G., Jones P., Dustan H. P. Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension. N Engl J Med. 1983 Feb 17;308(7):377–381. doi: 10.1056/NEJM198302173080707. [DOI] [PubMed] [Google Scholar]
  13. Curtiss C., Cohn J. N., Vrobel T., Franciosa J. A. Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure. Circulation. 1978 Nov;58(5):763–770. doi: 10.1161/01.cir.58.5.763. [DOI] [PubMed] [Google Scholar]
  14. Cushman D. W., Cheung H. S. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol. 1971 Jul;20(7):1637–1648. doi: 10.1016/0006-2952(71)90292-9. [DOI] [PubMed] [Google Scholar]
  15. Davis R., Ribner H. S., Keung E., Sonnenblick E. H., LeJemtel T. H. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme. N Engl J Med. 1979 Jul 19;301(3):117–121. doi: 10.1056/NEJM197907193010301. [DOI] [PubMed] [Google Scholar]
  16. Dzau V. J., Colucci W. S., Hollenberg N. K., Williams G. H. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation. 1981 Mar;63(3):645–651. doi: 10.1161/01.cir.63.3.645. [DOI] [PubMed] [Google Scholar]
  17. Dzau V. J., Colucci W. S., Williams G. H., Curfman G., Meggs L., Hollenberg N. K. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. N Engl J Med. 1980 Jun 19;302(25):1373–1379. doi: 10.1056/NEJM198006193022501. [DOI] [PubMed] [Google Scholar]
  18. Fouad F. M., MacIntyre W. J., Tarazi R. C. Noninvasive measurement of cardiopulmonary blood volume. Evaluation of the centroid method. J Nucl Med. 1981 Mar;22(3):205–211. [PubMed] [Google Scholar]
  19. Fouad F. M., Tarazi R. C., Bravo E. L., Hart N. J., Castle L. W., Salcedo E. E. Long-term control of congestive heart failure with captopril. Am J Cardiol. 1982 Apr 21;49(6):1489–1496. doi: 10.1016/0002-9149(82)90366-6. [DOI] [PubMed] [Google Scholar]
  20. Freeman R. H., Davis J. O. Physiological actions of angiotensin II on the kidney. Fed Proc. 1979 Aug;38(9):2276–2279. [PubMed] [Google Scholar]
  21. Freeman R. H., Davis J. O., Spielman W. S., Lohmeier T. E. High-output heart failure in the dog: systemic and intrarenal role of angiotensin II. Am J Physiol. 1975 Aug;229(2):474–478. doi: 10.1152/ajplegacy.1975.229.2.474. [DOI] [PubMed] [Google Scholar]
  22. Gavras H., Brown J. J., Lever A. F., Robertson J. I. Changes of renin in individual glomeruli in response to variations of sodium intake in the rabbit. Clin Sci. 1970 Apr;38(4):409–414. doi: 10.1042/cs0380409. [DOI] [PubMed] [Google Scholar]
  23. Gavras H., Faxon D. P., Berkoben J., Brunner H. R., Ryan T. J. Angiotensin converting enzyme inhibition in patients with congestive heart failure. Circulation. 1978 Nov;58(5):770–776. doi: 10.1161/01.cir.58.5.770. [DOI] [PubMed] [Google Scholar]
  24. Gould L., Reddy C. V. Phentolamine. Am Heart J. 1976 Sep;92(3):397–402. doi: 10.1016/s0002-8703(76)80121-4. [DOI] [PubMed] [Google Scholar]
  25. HOLLANDER W., JUDSON W. E., WILKINS R. W. The effects of intravenous apresoline (hydralazine) on cardiovascular and renal function in patients with and without congestive heart failure. Circulation. 1956 May;13(5):664–674. doi: 10.1161/01.cir.13.5.664. [DOI] [PubMed] [Google Scholar]
  26. Hall J. E., Guyton A. C., Smith M. J., Jr, Coleman T. G. Blood pressure and renal function during chronic changes in sodium intake: role of angiotensin. Am J Physiol. 1980 Sep;239(3):F271–F280. doi: 10.1152/ajprenal.1980.239.3.F271. [DOI] [PubMed] [Google Scholar]
  27. Hall J. E., Guyton A. C., Smith M. J., Jr, Coleman T. G. Chronic blockade of angiotensin II formation during sodium deprivation. Am J Physiol. 1979 Dec;237(6):F424–F432. doi: 10.1152/ajprenal.1979.237.6.F424. [DOI] [PubMed] [Google Scholar]
  28. Hricik D. E., Browning P. J., Kopelman R., Goorno W. E., Madias N. E., Dzau V. J. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med. 1983 Feb 17;308(7):373–376. doi: 10.1056/NEJM198302173080706. [DOI] [PubMed] [Google Scholar]
  29. Hsu C. H., Kurtz T. W., Slavicek J. M. Effect of exogenous angiotensin II on renal hemodynamics in the awake rat. Measurement of afferent arteriolar diameter by the microsphere method. Circ Res. 1980 May;46(5):646–650. doi: 10.1161/01.res.46.5.646. [DOI] [PubMed] [Google Scholar]
  30. Levens N. R., Peach M. J., Carey R. M. Role of the intrarenal renin-angiotensin system in the control of renal function. Circ Res. 1981 Feb;48(2):157–167. doi: 10.1161/01.res.48.2.157. [DOI] [PubMed] [Google Scholar]
  31. Meggs L. G., Hollenberg N. K. Converting enzyme inhibition and the kidney. Hypertension. 1980 Jul-Aug;2(4):551–557. doi: 10.1161/01.hyp.2.4.551. [DOI] [PubMed] [Google Scholar]
  32. Millard R. W., Higgins C. B., Franklin D., Vatner S. F. Regulation of the renal circulation during severe exercise in normal dogs and dogs with experimental heart failure. Circ Res. 1972 Dec;31(6):881–888. doi: 10.1161/01.res.31.6.881. [DOI] [PubMed] [Google Scholar]
  33. Pierpont G. L., Brown D. C., Franciosa J. A., Cohn J. N. Effect of hydralazine on renal failure in patients with congestive heart failure. Circulation. 1980 Feb;61(2):323–327. doi: 10.1161/01.cir.61.2.323. [DOI] [PubMed] [Google Scholar]
  34. Stern M. A., Gohlke H. K., Loeb H. S., Croke R. P., Gunnar R. M. Hemodynamic effects of intravenous phentolamine in low output cardiac failu;e. Dose-response relationships. Circulation. 1978 Jul;58(1):157–163. doi: 10.1161/01.cir.58.1.157. [DOI] [PubMed] [Google Scholar]
  35. Strauss H. W., Pitt B. Evaluation of cardiac function and structure with radioactive tracer techniques. Circulation. 1978 Apr;57(4):645–654. doi: 10.1161/01.cir.57.4.645. [DOI] [PubMed] [Google Scholar]
  36. Tarazi R. C., Fouad F. M., Ceimo J. K., Bravo E. L. Renin, aldosterone and cardiac decompensation: studies with an oral converting enzyme inhibitor in heart failure. Am J Cardiol. 1979 Oct 22;44(5):1013–1018. doi: 10.1016/0002-9149(79)90237-6. [DOI] [PubMed] [Google Scholar]
  37. Wallenstein S., Zucker C. L., Fleiss J. L. Some statistical methods useful in circulation research. Circ Res. 1980 Jul;47(1):1–9. doi: 10.1161/01.res.47.1.1. [DOI] [PubMed] [Google Scholar]
  38. Watkins L., Jr, Burton J. A., Haber E., Cant J. R., Smith F. W., Barger A. C. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. J Clin Invest. 1976 Jun;57(6):1606–1617. doi: 10.1172/JCI108431. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES